DNER and neuroblastoma: Although the retinoic acids (RAs) were applied in the high-risk NB differentiation therapy but the effectiveness is limited, low dose of JQ1 and RA could synergistically inhibit NB cells proliferation and induce differentiation which indicated BET inhibitor and RA might be a combination therapy in combating NB (Alleboina et al., 2021).